Medication info
Empagliflozin 25/5 mg (Empagliflozin, Linagliptin (Unmodified))

Empagliflozin 25/5 mg (Empagliflozin, Linagliptin (Unmodified))

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pink film-coated tablets that are convex on both sides
Packaging
Box - 30 tablets/box [10 tablets/PTP x 3], Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202502505 · Approved 2025.09.22 · Insurance code 646005870

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this drug may be increased to 25/5 mg once daily. Patients switching from concomitant therapy with empagliflozin and linagliptin to this drug should receive the same doses they were taking previously. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps improve blood glucose control in patients with type 2 diabetes. It assists in better blood glucose management when used alongside dietary and exercise therapies. It is especially suitable for improving blood glucose control through the combination use of empagliflozin and linagliptin. Therefore, this medication is used for the treatment of patients with type 2 diabetes.

How to take

Adult dose

The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this drug may be increased to 25/5 mg once daily. Patients switching from concomitant therapy with empagliflozin and linagliptin to this drug should receive the same doses they were taking previously. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication should not be used in certain patients. For example, those with allergies to the active ingredients or constituents of this medication, patients with type 1 diabetes, diabetic ketoacidosis patients, and those undergoing dialysis should not take this medication. For patients with impaired renal function, the effects of this medication may vary, so it is important to regularly check renal function before and during treatment. Caution is also needed if other medications that may affect renal function are being taken. Experience with this medication is limited in heart failure patients, so it should be used with caution. There is a risk of acute pancreatitis, so if symptoms such as severe abdominal pain occur, the medication should be stopped immediately and a doctor consulted. A skin condition called bullous pemphigoid may occur, and if blisters or rashes appear on the skin, immediate medical attention from a specialist should be sought. The most common side effect while taking this medication is urinary tract infection, but other side effects may include hypoglycemia, thirst, cough, constipation, itching, rashes, rhabdomyolysis, depletion of blood volume, increased urination, difficulty urinating, increased amylase, increased lipase, increased hematocrit, increased serum lipids, increased blood creatinine, headache, dizziness, drowsiness, weight gain, ECG abnormalities, and decreased hemoglobin. Especially when used alongside insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood glucose levels should be monitored closely. This medication may cause a decrease in fluid volume, so caution is needed in the elderly, those with low blood pressure, or patients with cardiovascular diseases. The risk of genital fungal infections may increase, so treatment should be sought if related symptoms appear. It is advisable not to use this medication during pregnancy or breastfeeding, and especially during breastfeeding, it is recommended to discontinue breastfeeding. The safety and efficacy of this medication have not been established in children under 18 years of age, so it is not recommended. In case of overdose, immediate contact with a medical institution is required for appropriate actions, and it is difficult to remove this medication through blood dialysis. This medication should be stored out of the reach of children and kept in its original container for safety. Finally, caution should be exercised during driving or operating machinery while taking this medication due to the risk of hypoglycemia.

Side effects

  • Urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • other genital infections
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 151 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • hypovolemia
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • vascular stent stenosis
  • vascular stent thrombosis
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • dizziness
  • kidney transplant failure
  • anemia
  • headache
  • drowsiness
  • burning mouth syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • acute kidney injury
  • end-stage renal disease
  • ureteral calculi
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary tract pain
  • urinary abnormalities
  • cervicitis
  • hyponatremia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • full-thickness retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • rib fracture
  • ligamentum teres syndrome
  • angina
  • palpitations
  • Prinzmetal's angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • hepatitis
  • otalgia
  • positional vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • thirst
  • obesity
  • weight gain
  • weight loss
  • insomnia
  • erectile dysfunction
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to store the medication at a cool room temperature between 1 to 30 degrees Celsius. Avoid storing it in excessively hot or cold places.

Appearance and packaging

Appearance

Pink film-coated tablets that are convex on both sides

Package unit

Box - 30 tablets/box [10 tablets/PTP x 3], Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.